Shandong ELAD Biotechnology Co., Ltd. was established in October 2019 and is headquartered within the Zhangjin Comprehensive Bonded Zone in Shandong, China. The company is dedicated to the research and treatment of liver diseases. Its proprietary ELAD bioartificial liver is an extracorporeal liver assist device. Additionally, within the bonded zone, the company boasts a high-tech cell bioreactor industrialization center spanning over 3,000 square meters, integrating scientific research, production, storage, and office facilities.

The center boasts a 10,000-grade GMP sterile purification workshop, equipped with cell biology research and development instruments from globally renowned brands such as ThermoFisher, Labconco, and Stockert; full-process semi-automated large-scale cell culture equipment from brands like ACFM and NUNC; and quality testing equipment like Bac T. Yiruit Biotech has achieved standardized and large-scale production of bioartificial livers.

Yiruit Biotech possesses the core technology and all assets of Yiruit Bioartificial Liver, including production and treatment instruments, research and development equipment, global patents, large-scale cell culture technology, and extensive clinical treatment experience.

Doctors embody benevolence and strive for excellence. In order to better align the OneRite bioartificial liver technology with China's national conditions, OneRite Biotech has adopted a "dual-channel" development strategy. On the one hand, it has submitted a registration application to the National Medical Products Administration; on the other hand, it has collaborated with top domestic infectious disease hospitals to file with the National Health Commission for clinical translational treatment as a treatment method. Based in Jinan, it aims to radiate across the country and ultimately achieve the goal of international development.